Abnormal brain iron homeostasis in human and animal prion disorders

Ajay Singh1, Alfred Orina Isaac, Xiu Luo

  • 1Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.

Plos Pathogens
|March 14, 2009
PubMed

Insights

Prion diseases cause neurotoxicity by sequestering iron in brain ferritin, leading to iron deficiency and neurotoxicity. This iron dyshomeostasis is linked to prion protein accumulation and offers new therapeutic targets.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Prion Disease Research

Background:

  • Prion diseases, including Creutzfeldt-Jakob disease (CJD), are linked to neurotoxicity from abnormal prion protein (PrPSc) accumulation.
  • Previous studies suggest brain iron dyshomeostasis may contribute to neurotoxicity in prion diseases, but mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of iron homeostasis in prion disease neurotoxicity across species.
  • To elucidate the mechanisms underlying iron dysregulation in prion-affected brains.

Main Methods:

  • Analysis of iron levels and iron-related proteins (transferrin, transferrin receptor, ferritin) in human, hamster, and mouse brains affected by prion disease.
  • Time-course studies in scrapie-infected hamsters.
  • Investigation of ferritin insolubility in prion-infected cell lines and human sCJD brain homogenates.
  • Assessment of transferrin resistance to proteinase-K digestion.

Main Results:

  • Prion disease brains exhibit increased total and redox-active iron, alongside elevated transferrin and transferrin receptor levels.
  • Iron deficiency is suggested by increasing transferrin levels with disease progression in hamsters.
  • Sporadic CJD brains show a correlation between PrPSc and transferrin, indicating PrPSc causes iron deficiency.
  • Neuronal iron deficiency is observed despite increased brain iron, due to iron sequestration in detergent-insoluble ferritin complexes.
  • Transferrin demonstrated resistance to proteinase-K digestion, serving as a potential postmortem biomarker.

Conclusions:

  • Iron sequestration in PrPSc-ferritin complexes induces bio-insufficient iron states and dyshomeostasis in prion diseases.
  • Redox-active iron and iron dyshomeostasis are implicated in prion disease-associated neurotoxicity.
  • Transferrin's resistance to proteinase-K offers a novel method for assessing postmortem brain iron levels.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...